EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Positive impact of obesity on the prognosis of liver cirrhosis

Kei Endo iD, Keisuke Kakisaka iD, Tamami Abe, Kenji Yusa, Ippeki Nakaya, Takuya Watanabe, Akiko Suzuki, Yuichi Yoshida, Takayoshi Oikawa, Akio Miyasaka iD, Hidekatsu Kuroda, Takayuki Matsumoto

Journal of Gastroenterology and Hepatology · 2024

DOI: 10.1111/jgh.16590 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Journal of Gastroenterology and Hepatology, 2024. Verfasst von Kei Endo und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, Department of Internal Medicine, Iwate Medical University School of Medicine, Yahaba, Japan. Hauptthemen laut MEDLINE: Liver Cirrhosis, Obesity, Sarcopenia. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 50 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aim The study aims to determine the prognostic impact of obesity, sarcopenic obesity, and dynapenic obesity in patients with chronic liver disease.

Methods

This retrospective observational study enrolled patients with chronic hepatitis ( n = 746) and liver cirrhosis ( n = 434) without hepatocellular carcinoma at entry. The patients were evaluated for sarcopenia and obesity between April 2016 and April 2022. Obesity was defined as a body mass index of ≥ 25 kg/m 2 . Sarcopenic obesity was defined as low skeletal muscle mass (pre‐sarcopenia) with obesity and dynapenic obesity was defined as low muscle strength (dynapenia) with obesity. The effects of obesity on survival were evaluated retrospectively.

Results

The mean observation period was 2.5 years. Obesity, sarcopenic obesity, and dynapenic obesity were found in 271 (45.5%), 17 (2.9%), and 21 (3.5%) men, and 261 (44.7%), 59 (10.1%), and 53 (9.1%) women, respectively. A multivariate Cox proportional hazards model revealed that Child–Pugh class, dynapenia (hazard ratio [HR] 3.89), elderly (≥ 65 years old) (HR 2.11), and obesity (HR 0.58) were independently associated with overall survival (OS). However, neither sarcopenic nor dynapenic obesity were associated with OS. In patients with cirrhosis, the OS of the obese group was significantly higher than that of the non‐obese group. The effect of obesity on OS was significant in elderly patients, but not in younger patients.

Conclusions

Sarcopenic and dynapenic obesity seem unrelated to the prognosis of patients with chronic liver disease. Obesity has a positive effect on the prognosis of elderly patients with cirrhosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver CirrhosisObesitySarcopeniaHumansMaleFemalePrognosisRetrospective StudiesMiddle AgedAgedMuscle StrengthAge FactorsProportional Hazards ModelsHepatitis, ChronicBody Mass IndexAdultSurvival Rate

Stichwörter der Autor:innen

DynapeniaDynapenic obesityObesityObesity paradoxPre‐sarcopeniaSarcopenic obesity

Autor:innen und Institutionen

  • Division of Gastroenterology and Hepatology, Department of Internal Medicine, Iwate Medical University School of Medicine, Yahaba, Japan.

ORCID-Profile: Kei Endo, Keisuke Kakisaka, Akio Miyasaka

Zitieren

APA

Endo, K., Kakisaka, K., Abe, T., Yusa, K., Nakaya, I., Watanabe, T., Suzuki, A., Yoshida, Y., Oikawa, T., Miyasaka, A., Kuroda, H., & Matsumoto, T. (2024). Positive impact of obesity on the prognosis of liver cirrhosis. Journal of Gastroenterology and Hepatology. https://doi.org/10.1111/jgh.16590

Vancouver

Endo K, Kakisaka K, Abe T, Yusa K, Nakaya I, Watanabe T, et al. Positive impact of obesity on the prognosis of liver cirrhosis. Journal of Gastroenterology and Hepatology. 2024. doi:10.1111/jgh.16590

BibTeX
@article{Endo2024,
  author = {Endo, Kei and Kakisaka, Keisuke and Abe, Tamami and Yusa, Kenji and Nakaya, Ippeki and Watanabe, Takuya and Suzuki, Akiko and Yoshida, Yuichi and Oikawa, Takayoshi and Miyasaka, Akio and Kuroda, Hidekatsu and Matsumoto, Takayuki},
  title = {Positive impact of obesity on the prognosis of liver cirrhosis},
  journal = {Journal of Gastroenterology and Hepatology},
  year = {2024},
  doi = {10.1111/jgh.16590}
}
Kostenlos starten →